Characterisation of cationic amphiphilic cyclodextrins for neuronal delivery of siRNA: effect of reversing primary and secondary face modifications

dc.contributor.authorO'Mahony, Aoife M.
dc.contributor.authorDoyle, D.
dc.contributor.authorDarcy, Raphael
dc.contributor.authorCryan, John F.
dc.contributor.authorO'Driscoll, Caitríona M.
dc.contributor.funderScience Foundation Irelanden
dc.contributor.funderIrish Research Council for Science Engineering and Technologyen
dc.contributor.funderIrish Drug Delivery Networken
dc.date.accessioned2013-01-09T12:08:13Z
dc.date.available2013-01-09T12:08:13Z
dc.date.issued2012-12-18
dc.date.updated2013-01-04T15:01:51Z
dc.description.abstractSignificant research is focused on the development of non-viral vectors for delivery of siRNA to neurons and the central nervous system. Cyclodextrins (CDs) have shown great promise as efficient and low toxicity gene delivery vectors in various cell types. Here, we investigate two CDs for siRNA delivery in a neuronal cell model. These CDs were substituted on opposite faces (primary and secondary) with amphiphilic and cationic groups. Physical properties of CD.siRNA complexes, including size, charge and stability were measured. In vitro investigations were carried out in immortalised hypothalamic neurons. Neuronal cell uptake was measured by flow cytometry and cytotoxicity was assessed by MTT assay. Knockdown of a luciferase reporter gene was used as a measure of gene silencing efficiency. Both CDs interacted with siRNA, yielding nanosized cationic complexes which exhibited good stability on storage. A favourable toxicity profile was demonstrated for the CD.siRNA complexes. However, only one of the two CDs mediated high levels of neuronal uptake and efficient gene silencing, equivalent to those achieved with a commercial lipid-based vector. Despite the suitability of both CDs as siRNA delivery vectors in terms of their ability to complex siRNA and the properties of the complexes yielded, only one CD achieved good transfection efficiency. This was likely due to the differences in their chemical structures. The effective CD offers great potential as a novel non-toxic vector for neuronal siRNA delivery.en
dc.description.sponsorshipScience Foundation Ireland(Grant no. 07/SRC/B1154); Irish Research Council for Science Engineering and Technology (Embark initiative)en
dc.description.statusPeer revieweden
dc.description.versionAccepted Versionen
dc.format.mimetypeapplication/pdfen
dc.identifier.citationO'Mahony A.M., Doyle D., Darcy R., Cryan J.F., O'Driscoll C.M. (2012) 'Characterisation of cationic amphiphilic cyclodextrins for neuronal delivery of siRNA: Effect of reversing primary and secondary face modifications'. European Journal of Pharmaceutical Sciences, 47(5), pp. 896–903. http://dx.doi.org/10.1016/j.ejps.2012.08.020en
dc.identifier.doi10.1016/j.ejps.2012.08.020
dc.identifier.endpage903en
dc.identifier.issn0928-0987
dc.identifier.issued5en
dc.identifier.journaltitleEuropean Journal of Pharmaceutical Sciencesen
dc.identifier.startpage896en
dc.identifier.urihttps://hdl.handle.net/10468/873
dc.identifier.volume47en
dc.language.isoenen
dc.publisherElsevieren
dc.rights© 2012, Elsevier. NOTICE: this is the author’s version of a work that was accepted for publication in European Journal of Pharmaceutical Sciences. Changes resulting from the publishing process, such as peer review, editing, corrections, structural formatting, and other quality control mechanisms may not be reflected in this document. Changes may have been made to this work since it was submitted for publication. A definitive version was subsequently published in European Journal of Pharmaceutical Sciences, [47, 18 December 2012] http://dx.doi.org/10.1016/j.ejps.2012.08.020en
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/4.0/en
dc.subjectModified cyclodextrinsen
dc.subjectsiRNA deliveryen
dc.subjectNeuronsen
dc.subjectLow-toxicityen
dc.subject.lcshCyclodextrinsen
dc.titleCharacterisation of cationic amphiphilic cyclodextrins for neuronal delivery of siRNA: effect of reversing primary and secondary face modificationsen
dc.typeArticle (peer-reviewed)en
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
AMOM_characterisationAV2012.pdf
Size:
616.9 KB
Format:
Adobe Portable Document Format
Description:
Accepted Version
License bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
2.71 KB
Format:
Item-specific license agreed upon to submission
Description: